Product Images Lurasidone Hydrochloride

This is a medication label for Lurasidone Hydrochloride tablets. The National Drug Code is 47335-579-83 and contains 30 tablets. The medication guide should be dispensed to each patient that receives the prescription. It also includes a lot number and expiration date.*

This is a label information for Lurasidone Hydrochloride Tablets. The label includes the National Drug Code (NDC), which is 47335-578-83. It also mentions that the medication should be dispensed with a medication guide, under the supervision of a pharmacist. The rest of the text contains unclear characters, therefore the complete description cannot be provided.*

This is a description for Lurasidone Hydrochloride Tablets with medication dispensing instructions for pharmacists. It also includes product codes such as NDC, GTIN, SN, LOT, and EXP with the prescription being available only. The text also shows the quantity of 30 tablets with a reference number of 5231880.*

This is a description of a medication called Lurasidone Hydrochloride Tablets in a 60 mg dosage. The medication is identified by the NDC code 47335-639-83. A pharmacist is advised to dispense the medication with a Medication Guide to every patient. The Lot number is AAAEA and the medication is to be used only with a prescription (Rx only). The expiration date is indicated as MMAYYYY. No other information is available.*

This is a label for Lurasidone Hydrochloride Tablets with the National Drug Code (NDC) 47335-685-83. The label indicates that the product is for prescription use only, and should be dispensed with a medication guide to each patient. There are 30 tablets in each package and the expiration date is MM/YYYY. However, it seems that some of the characters in the text might have been misinterpreted by the , as there are some parts that do not appear to make sense.*

Impact of other drugs on Lurasidone PK has been evaluated. The text presents the PK fold change and 90% CI of interacting drugs such as Strong CYP3A4 Inhibitor-Ketoconazole 400 mg/day, Moderate CYP3A4 Inhibitor-Ditiazem 240 mg/day, Strong CYP3A Inducer- Ritampin 600 mg/day, and Lithium 600 mg BID. The text also reports Cmax, Auc, and Ciax parameters. The change relative to lurasidone alone is described as well.*

This appears to be a table that lists drugs and their potential interactions. The first column indicates if a drug is an "interacting drug." The second column lists various drugs, some of which are substrates of P-glycoprotein and CYP1A. The third column includes a contraceptive drug called "Orsl Contraceptve" and a radiolabeled drug called "Ebiny radiol Noregestromin." The fourth column lists a drug called "Litium" at a dose of 600mg twice a day. The last section of the table provides information about the fold change and 90% confidence interval for changes in cmax (maximum serum concentration of drug) relative to the interactive drug alone.*